← Leaderboards
Connie Suders
Leidos Biomedical Research, Inc.
$87,695,336
Attributed
$87,695,336
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61M · FY2018–23$100M$75M$50M$25M$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$87,695,336 · 1
By mechanism
N01$60,987,483 · 1
N02$26,707,853 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
- Leonard Freedmand$281,097,701
Others in their field
Other Emerging Leaders on “Common Neoplasm”
- Leonard Freedman · Leidos Biomedical Research, Inc.$87,585,479
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$76,942,916
- Martha Hering · Westat, Inc.$57,098,843
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Lynn Briscoe · Leidos Biomedical Research, Inc.$29,919,638
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
Research focus
Common NeoplasmMalignant NeoplasmsXenograft Procedure